Clovis Oncology (CLVS) Misses Q2 EPS by 1c

Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($2.10), $0.01 worse than the analyst estimate of ($2.09).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Super Micro Computer (SMCI) Falls 6%
• P&G lifts annual profit forecast on strong US consumer demand, easing costs
• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance